Biocompatible hole scavenger-assisted graphene oxide dots for photodynamic cancer therapy
Photodynamic therapy (PDT) receives scholarly attention for its low invasiveness and mild adverse effects. Among the reactive oxygen species for PDT, H 2 O 2 is advantageous for achieving long life and low cytotoxicity. Nitrogen-doped graphene oxide dots (NGODs), which are small (∼4.4 nm) and highly...
Gespeichert in:
Veröffentlicht in: | Nanoscale 2021-05, Vol.13 (18), p.8431-8441 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Photodynamic therapy (PDT) receives scholarly attention for its low invasiveness and mild adverse effects. Among the reactive oxygen species for PDT, H
2
O
2
is advantageous for achieving long life and low cytotoxicity. Nitrogen-doped graphene oxide dots (NGODs), which are small (∼4.4 nm) and highly biocompatible, can serve as a photosensitizer for PDT. The charge transfer in NGODs is efficient because the NGOD structure is highly crystalline and its carbon-π orbitals are extensively conjugated with nitrogen-nonbonding orbitals. In the presence of ascorbic acid (AA), to scavenge photogenerated holes, NGODs effectively produce H
2
O
2
under white-light irradiation and their H
2
O
2
rate is proportional to the AA concentration. This AA-supplemented PDT effectively kills lung, head and neck, colon, and oral cancer cells and it is highly safe for normal cells. During PDT, the NGODs are uptaken into the cell body and they produce concentrated H
2
O
2
and subsequently induce both the apoptosis and necrosis pathways for cell death. The unique structure of NGODs confines the transfer of the photogenerated electrons for H
2
O
2
production. This study demonstrates the high potential for efficacious and accurate deployment of the proposed NGOD-AA combination in PDT.
Tuning of the nitrogen-doped graphene oxide dot and ascorbic acid concentrations can selectively kill cancer cells through either apoptosis or necrosis. |
---|---|
ISSN: | 2040-3364 2040-3372 |
DOI: | 10.1039/d1nr01476e |